Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,621,178
+$1,776,960 QoQ
Shares Held
6,354
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
5.32%
of 13F equity value
Holder Rank
#1,417
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $26,299,020 across 9 Drug Manufacturers - General names. LLY ranks #1 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
6,354 | $7,621,178 | |
| 2 | JNJ |
Johnson & Johnson
|
18,218 | $4,626,825 | |
| 3 | AMGN |
Amgen Inc
|
9,210 | $3,335,125 | |
| 4 | ABBV |
AbbVie Inc.
|
12,200 | $3,070,008 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,480 | $2,760,180 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
20,620 | $2,605,130 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,150 | $1,218,663 | |
| 8 | PFE |
Pfizer Inc
|
27,500 | $662,200 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,621,178 | 6,354 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,844,218 | 6,354 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,819,372 | 7,276 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $7,153,888 | 9,376 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,997,061 | 8,976 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,776,768 | 9,416 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,685,512 | 12,546 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,741,796 | 10,996 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,199,472 | 23,415 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $19,966,343 | 25,665 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,485,269 | 26,565 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,496,329 | 23,265 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,145,309 | 23,765 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,161,376 | 23,765 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,736,943 | 18,415 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,954,490 | 18,415 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,970,695 | 18,415 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,151,522 | 28,465 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $8,138,822 | 29,465 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,407,200 | 40,715 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,495,682 | 37,015 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,727,296 | 46,715 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,706,234 | 51,565 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,632,651 | 51,565 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,059,206 | 30,815 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,898,896 | 35,315 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||